2003
U.S. Study Continues Guidant''s Leadership in Clinical Science St. Paul, Minn. and Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular...
MULTI-LINK PENTA Stent System Brings Guidant''s Outstanding Stent Design Technology to Japanese Physicians and Patients Indianapolis, Ind. and Tokyo - Guidant Corporation (NYSE: GDT), a world...
FX miniRAIL Coronary Device Aims to Expand Physicians'' Options In the Treatment of De Novo Lesions and In-Stent Restenosis Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that Dana G. Mead, Jr., currently vice president, Corporate...
Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will...
Company Sets Date for Annual Meeting of Shareholders Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced...
INSIGNIA Entra is Small, Smart and Long-Lasting Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease,...
Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, will host a conference call to provide an...
Medicare Coverage Advisory Committee Recommends Expanding Coverage to Include MADIT II Patients Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in...
Background Materials Available for Review Online Indianapolis, Ind. - Guidant today announced that background materials from Guidant have been provided to the Centers for Medicare and Medicaid...
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that Ron Lattanze, president, Guidant Japan, has been...
Degois-Sainz Joins Guidant Management Committee Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that...
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) announced today that Nicky Spaulding currently president, Cardiac Surgery, Guidant, has been named president, Guidant Europe, Middle...
Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will...
Enhanced Guideline Reflects Results of MADIT II Trial Indianapolis, Ind. and Brussels, Belgium - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular...
More Than 97 Percent of Patients Studied Experienced Stable or Shrinking Aneurysm Size Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...
Guidant Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a global leader in the treatment of cardiac and vascular disease, today announced that it...
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, will conduct a live webcast of its fourth quarter 2002 earnings...
VITALITY AVT Offers Complete Ventricular and Atrial Therapy Options Indianapolis, Ind. and Brussels - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and...
CONTAK RENEWAL Includes State-of-the-Art Therapies and Diagnostics for Improved Management of Heart Failure Patients Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a...
Wireless Telecommunications Enable Remote Monitoring of Heart Patients with Implanted Devices Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced preliminary fourth quarter revenues of approximately...
Guidant Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it...
Conditions to Closing Guidant-Cook Merger Not Satisfied Company to Host Webcast/Conference Call January 3 at 8:30 AM EST Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world...